Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cortex Q4 net loss widens
Cortex is a neuroscience company engaged in novel drug therapies for treating psychiatric disorders, neurological diseases and sleep apnea. The company has posted loss from operations of $986,000,
Cortex is a neuroscience company engaged in novel drug therapies for treating psychiatric disorders, neurological diseases and sleep apnea. The company has posted loss from operations of $986,000,
The facility is already certified by the Sustainable Forestry Initiative (SFI), and the dual third-party validations of MWV’s sustainable fiber sourcing practices help assure customers and consumers of
Medidata Solutions is a provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. ViroPharma has choosen Rave as an enterprise-wide EDC system based
XL-protein took over worldwide rights for PASylation technology under a license agreement signed with TUM via Bayerische Patentallianz in 2009. The new patent covers covers the use of
GenSpera owns and controls all rights to Ac-GKAFRR-L12ADT and anticipates a strategic partnership to maximize the value of the drug as it progresses through future clinical trials. GenSpera
ZeaVision claims that EyePromise Restore includes the highest available level of Zeaxanthin, the predominant carotenoid found in the fovea, responsible for central vision. ZeaVision president Chris Barber said
As part of the research agreement, bluebird bio has the option to draw upon an additional amount of up to $2.8m in credit toward the manufacturing of cGMP
As per the agreement, Pharmaron is expected to provide Isis Pharma with certain nucleoside phosphoramidites during the next two years. Isis Pharma Medicinal Chemistry Eric Swayze said they
PsiOxus expects to recruit around 132 cachectic patients with colorectal and lung cancer in centers in Europe and Asia. The trial is designed to demonstrate reversal of weight
The clinical trial will be conducted in Hospital Universitario Puerta de Hierro de Majadahonda in Madrid and Clinica Universidad de Navarra in Pamplona. According to researchers at the